Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Socie

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Human Immunology|September 3, 2013
Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host diseaseWahid Boukouaci, Reem Al-Daccak, Nicolas Dulphy, et al.
Bone Marrow Transplantation|September 2, 2023
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMTArnon Nagler, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation|September 19, 2019
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT studyKatie S Gatwood, Myriam Labopin, Bipin N Savani, et al.
Leukemia Research|May 25, 2015
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Transplantation|March 20, 2013
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignanciesVanderson Rocha, Myriam Labopin, Annalisa Ruggeri, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TCPatrice Chevallier, Mohamad Mohty, Bruno Lioure, et al.
Leukemia|November 16, 2019
The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantationArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Haematologica|September 17, 2013
Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuriaTommaso Rondelli, Antonio M Risitano, Régis Peffault de Latour, et al.
International Journal of Immunogenetics|July 26, 2018
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantationJean Norden, Kim F Pearce, Julie A E Irving, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Human Immunology|September 3, 2013
Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host diseaseWahid Boukouaci, Reem Al-Daccak, Nicolas Dulphy, et al.
Bone Marrow Transplantation|September 2, 2023
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMTArnon Nagler, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation|September 19, 2019
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT studyKatie S Gatwood, Myriam Labopin, Bipin N Savani, et al.
Leukemia Research|May 25, 2015
Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Transplantation|March 20, 2013
Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignanciesVanderson Rocha, Myriam Labopin, Annalisa Ruggeri, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2008
Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TCPatrice Chevallier, Mohamad Mohty, Bruno Lioure, et al.
Leukemia|November 16, 2019
The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantationArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Haematologica|September 17, 2013
Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuriaTommaso Rondelli, Antonio M Risitano, Régis Peffault de Latour, et al.
International Journal of Immunogenetics|July 26, 2018
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantationJean Norden, Kim F Pearce, Julie A E Irving, et al.
Pageof 8